LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Historical Holders from Q1 2024 to Q3 2025

Symbol
LENZ on Nasdaq
CUSIP
52635N103
Type / Class
Equity / Common Stock, $0.00001 par value per share
Shares outstanding
28.2M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
29.1M
Holdings value
$1.36B
% of all portfolios
0.011%
Grand Portfolio weight change
+0%
Number of holders
164
Number of buys
121
Number of sells
-26
Average Value change %
+0.01%
Average buys %
+0.009%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% $199M 4.28M FMR LLC Oct 31, 2025
RA CAPITAL MANAGEMENT, L.P. 13.6% -10% $199M $210K 4.27M +0.11% RA Capital Management, L.P. Nov 5, 2025
BlackRock, Inc. 5.1% $67.2M 1.44M BlackRock, Inc. Sep 30, 2025
Point72 Asset Management, L.P. 4.8% $63.2M 1.36M Steven A. Cohen Sep 30, 2025
Paradigm Biocapital Advisors LP 3.8% -28% $50M -$16.1M 1.07M -24.4% Paradigm BioCapital Advisors LP Sep 30, 2025
Versant Venture Capital VI, L.P. 3.4% -17.5% $48.9M -$6.19M 1.05M -11.2% Versant Venture Capital VI, L.P. Nov 5, 2025

Institutional Holders of LENZ Therapeutics, Inc. - Common Stock, $0.00001 par value per share (LENZ)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 29.1M $1.36B +$225M $46.58 164
2025 Q2 24.7M $725M +$108M $29.31 113
2025 Q1 21.1M $542M +$29.1M $25.71 105
2024 Q4 19.9M $573M +$35.3M $28.87 93
2024 Q3 18.7M $445M -$1.42M $23.74 78
2024 Q2 18.9M $327M +$45.1M $17.29 63
2024 Q1 16.2M $361M +$360M $22.33 54